New Blood Test Offers Breakthrough in Myeloma Diagnosis and Monitoring

New blood test offers breakthrough in myeloma diagnosis and monitoring

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions.

Blood test for multiple myeloma offers alternative to bone marrow biopsies

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, utilizes single-cell sequencing to profile circulating tumor cells (CTCs) in the blood, offering a non-invasive alternative to traditional bone marrow biopsies.

New SWIFT-seq Blood Test Offers Non-Invasive Alternative to Bone Marrow Biopsies for Multiple Myeloma Detection

A new blood test, known as SWIFT-seq, has been develope […] The post New SWIFT-seq Blood Test Offers Non-Invasive Alternative to Bone Marrow Biopsies for Multiple Myeloma Detection first appeared on GeneOnline News. The post New SWIFT-seq Blood Test Offers Non-Invasive Alternative to Bone Marrow Biopsies for Multiple Myeloma Detection appeared first on GeneOnline News.

Blood Test Could Replace Bone Marrow Biopsies in Multiple Myeloma

SWIFT-seq revolutionizes multiple myeloma diagnosis, offering a non-invasive blood test that enhances monitoring and risk assessment for patients.

Blood-based test provides new diagnostic approach for multiple myeloma

Test of circulating tumor cells offers less invasive option for multiple myeloma surveillance, staging, and biological study compared to bone marrow biopsies

Dana-Farber Cancer Institute Introduces Revolutionary Blood Test for

Boston, MA — In an era where precision medicine is rapidly evolving, a groundbreaking advancement from researchers at the Dana-Farber Cancer Institute promises to revolutionize the diagnosis and monitoring of multiple myeloma (MM) and its precursor stages. The newly developed blood test, known as SWIFT-seq, leverages the power of single-cell sequencing technology to profile circulating […]